From: Impact of heterotopic ossification following lumbar total disk replacement: a systematic review
 |  |  |  |  |  | Surgical Level/Segment | ||||
---|---|---|---|---|---|---|---|---|---|---|
Reference | Male (%) | Mean Age | Device design | Smokers(%) | Surgery | L1-2 | L2-3 | L3-4 | L4-5 | L5-S1 |
[52] | 52% | 42.8 | XL-TDR | N/A | Lateral Approach | N/A | 3 | 10 | 42 | N/A |
[47] | 50% | 39.9 | Maverick | 28.9 | Anterior Approach | N/A | N/A | N/A | N/A | N/A |
[67] | 33% | 44.8 | ProDisc II (92%), Charite 8% | N/A | Anterior Approach | N/A | N/A | N/A | N/A | N/A |
[68] | 53% | 59.4 | Charite III | N/A | Anterior Approach | N/A | N/A | 1 | 18 | 6 |
[53] | N/A | N/A | M6-L | N/A | N/A | N/A | N/A | 10 | 43 | 103 |
[54] | 58% | 45.3 | XL-TDR | 20.3 | Lateral Approach | 2 | 3 | 11 | 48 | N/A |
[56] | 44% | 41.4 | Charite III | N/A | Anterior Approach | N/A | N/A | N/A | N/A | N/A |
[55] | 60% | 45.1 | Active L | N/A | Anterior Approach | N/A | N/A | 3 | 23 | 10 |
[57] | 31% | 44.3 | ProDisc L | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
[58] | 50% | 41 | AcroFlex | 39.2 | Anterior RPA | N/A | N/A | N/A | N/A | N/A |
[59] | 44% | 42.6 | XL-TDR | N/A | Lateral Approach | N/A | N/A | 4 | 17 | N/A |
[69] | 48% | N/A | Charite III | N/A | Anterior Approach | 1 | 1 | 3 | 9 | 10 |
[60] | 37% | 43.8 | Prodisc (91%) and Charite (9%) | N/A | Anterior Approach | N/A | N/A | 3 | 46 | 33 |
[61] | 46% | 36 | Charite III | N/A | Anterior Approach | N/A | N/A | 4 | 26 | 30 |
[70] | 38% | 44 | Charite I (25%), II(40%), III(35%) | N/A | Anterior Approach | N/A | N/A | 2 | 35 | 26 |
[48] | 47% | 39.6, 39.9 | Kineflex (52%) Charite III (48%) Control | N/A | Anterior Approach | N/A | N/A | N/A | 46, 48 | 158, 142 |
[62] | 41% | 39.6 | Charite III | N/A | Anterior Approach | N/A | N/A | 6 | 69 | 72 |
[49] | 52% | 40 | ChariteIII (67%) AND BAk fusion (33%) | N/A | Anterior Approach | N/A | N/A | N/A | 26 | 64 |
[50] | 52% | 39,40 | Active L (67%), Prodisc OR charite (33%) | 39.2 | Anterior Approach | N/A | N/A | N/A | 62,34 | 156,72 |
[63] | 39% | 39 | Charite III | 61.4 | Anterior Approach | N/A | N/A | N/A | 4 | 53 |
[64] | 39% | 44 | Maverick | 29.7 | Anterior Approach | N/A | N/A | 2 | 27 | 35 |
[71] | 44% | 38 | Charite III | N/A | Anterior Approach | N/A | 1 | 2 | 19 | 11 |
[66] | 48% | 37.1 | Maverick | N/A | Anterior Approach | N/A | 1 | 2 | 19 | 28 |
[72] | 42% | 36.4 | Charite III | N/A | Anterior Approach | N/A | N/A | 1 | 25 | 82 |
[51] | 50% | 40.3 | Charite III (68%), BAK Fusion (32%) | N/A | Anterior Approach | N/A | N/A | N/A | 19 | 41 |
[65] | 50% | 41 | Acroflex | 39.2 | Anterior Approach | N/A | N/AA | N/A | 9 | 23 |